Epigallocatechin-3-gallate (EGCG) inhibits interleukin-1β-induced activation of mitogen activated protein kinase (p38-MAPK, JNK/SAPK), nuclear factor-κB (NF-κB), expression of nitric oxide synthase and production of nitric oxide in human osteoarthritis chondrocytes.